Email Updates

You are here

Home

6 JULY 2018 VOLUME 19 ISSUE 27

Media Coverage

  • This new dating research proves so many people still believe outdated HIV myths

    Dating can be an absolute minefield as it is, with ruthless app users judging you within a second and swiping left for the seemingly most insignificant things. But new research shows they're also making decisions on who to match with, and who to reject, based on suuuuper outdated myths.

    July 6, 2018
    General
    Cosmopolitan

  • HCV status not linked to diabetes in patients with HIV

    Among patients with HIV, hepatitis C (HCV) infection does not increase the risk with diabetes, but cirrhosis does, according to a new nationwide study in France.

    July 6, 2018
    Hormonal Contraceptives and HIV
    MD Magazine

  • Rise in HIV rates among Asian-born gay men prompts call for more services

    An alarming trend in the rise of HIV among Asian gay men has prompted health and support services to call for expanded access to HIV-prevention drugs and more education programs targeting specific ethnicities.

    July 6, 2018
    General
    SBS News

  • HIV is not the only risk – using condoms or getting tested can pose risks to trust and relationships

    Perceptions of risk are crucial in explaining why people do or do not make use of HIV-prevention interventions. But considerations of risk need to go beyond the risk of HIV infection to consider the personal, social, emotional, and economic risks associated with using condoms, getting tested or taking other preventative action, researchers argue.

    July 6, 2018
    Male and Female Condoms
    aidsmap

  • Health ministry bans use of HIV drug

    The Health ministry has warned counties to stop prescribing a HIV drug linked to birth defects in HIV-positive women. Through Director of Medical Services Jackson Kioko, the ministry has further directed county health directors to ensure that pregnant and breastfeeding mothers to whom a front-line drug, dolutegravir (DTG), has been prescribed, continue their current prescription until they stop breastfeeding.

    July 5, 2018
    Hormonal Contraceptives and HIV, Treatment
    Daily Nation

  • Many taking PrEP in San Francisco not having recommended HIV and STI screens

    Laboratory monitoring does not meet guideline standards in up to a third of people prescribed pre-exposure prophylaxis (PrEP) investigators report in Open Forum Infectious Diseases. Almost a quarter of people were not tested for HIV before starting PrEP and follow-up tests were not ordered for a third of testing intervals.

    July 5, 2018
    PrEP
    aidsmap

  • How one woman inspired HIV+ children who had given up on life

    When I set to meet with Ms Namusoke Asia Mbajja, the director of PINA Uganda, I didn’t really know what to expect. Colleagues had for several months told me to meet a woman who is making a difference in the lives of youngsters born with HIV.

    July 5, 2018
    General
    Watchdog Uganda

  • Nigeria: US commits $5.1 billion to HIV/AIDS in Nigeria

    The United States says it has committed more than $5.1 billion to the fight against HIV/AIDS in Nigeria through its President's Emergency Plan for AIDS Relief (PEPFAR).

    July 5, 2018
    General
    All Africa

  • Preventing HIV

    Re “The End of Safe Gay Sex?,” by Patrick William Kelly (Op-Ed, nytimes.com, June 26): Condoms work when used consistently. Men who have sex with men who cannot use condoms every time, or will not, should not be shamed and further alienated from strategies that prevent HIV and promote sexual health.

    July 5, 2018
    Male and Female Condoms, PrEP
    New York Times

  • Our best shot: South African HIV vaccine shows promise

    The latest results from a small HIV vaccine trial taking place in South Africa have shown promise, revealing that people’s immune systems recognised the vaccine and responded strongly.

    July 5, 2018
    HIV Vaccine
    Times Select

  • Out-of-pocket costs put HIV prevention drug out of reach for many at risk

    Public health officials are expanding efforts to get the HIV prevention pill into the hands of those at risk, in a nationwide effort to curb infections. But the officials are hitting roadblocks — the drug’s price tag, which has surged in recent years, and changes in insurance coverage that put a heftier financial burden on patients.

    July 4, 2018
    PrEP
    Philly Voice

  • Portugal: 'Historic day' as two of three HIV targets of WHO programme met

    Portugal's secretary of state for health, Fernando Araújo, has hailed the "historic day" on which the country has achieved the goals of diagnosing more than 90% of people with HIV and of having more than 90% of those who are in treatment no longer able to transmit the infection.

    July 4, 2018
    Treatment
    Macau Business

  • The battle for PrEP on the NHS

    On the 70th anniversary of the NHS, this is the incredible story of the battle for PrEP - a legal fight which saw doctors, activists and AIDS charities come together to overturn the NHS decision. Watch “The People vs The NHS: Who Gets the Drugs?”

    July 4, 2018
    PrEP
    BBC

  • Drug users tell story behind HIV outbreak

    Researchers have known for decades programs that provide clean syringes to injection drug users lower transmission rates of diseases like HIV and hepatitis C. Now, they have personal stories to back the numbers.

    July 3, 2018
    General
    HIV Plus Mag

  • Londoners urged to prevent HIV this summer

    A new city-wide campaign by London boroughs, urges Londoners to look after their sexual health and prevent HIV transmission this summer.

    July 3, 2018
    General
    GScene

  • Americans broadly favor government funding for medical and science research

    Americans are strongly supportive of the government investing in research in medicine and science, according to a new Pew Research Center survey. Around eight-in-ten U.S. adults say government investments in medical research (80%), engineering and technology (80%) or basic scientific research (77%) usually pay off in the long run.

    July 3, 2018
    General
    Pew Research Center

  • HIV prevention charity wins rare federal grant in Russia

    The grant of around 100,000 rubles (£1,200) was the first awarded to charity workers involved in the “To live” project. Charity workers may approach people in nightclubs and offer them to take an HIV test and, should the result show a positive, would offer to accompany them to a local AIDS centre. Part of the money will be spent on renting a room close to the centre.

    July 3, 2018
    General
    PinkNews

  • What sex workers have to say about HIV after FOSTA/SESTA

    When we asked numerous sex workers what effects FOSTA/SESTA have had on their ability to maintain agency over their sexual health, the feedback was quite shocking (though not altogether surprising).

    July 3, 2018
    General
    The Body

  • For immigrants living with HIV, an impossible choice between viral suppression and deportation

    Within those translucent, orange-tinted cylinders is her antiretroviral medication. Without it, the grandmother's viral load would skyrocket, her CD4 count would drop, and the microscopic defenses within her body would slowly shut down, leaving her vulnerable to the sorts of opportunistic infections that often claim the lives of those living with HIV. She knows that she must go see her HIV clinician to have her prescriptions refilled and blood tests done, but she is afraid of what might happen.

    July 3, 2018
    The Body

  • HIV activists urge Gilead to #breakthepatent on PrEP

    Since it was authorized by the Food and Drug Administration in 2012, PrEP (pre-exposure prophylaxis) has provoked a lively discussion among AIDS activists and public health officials. However, most are unaware that a biopharmaceutical company known as Gilead Sciences — owner of the Truvada/PrEP patent — holds all of the cards.

    July 3, 2018
    PrEP
    Medium

  • Women likely shy away from PrEP because of fear of stigma

    A major impediment to the scale-up of Truvada (tenofovir disoproxil fumarate/emtricitabine) as pre-exposure prophylaxis (PrEP) among at-risk women is their fear of stigma related to taking the daily HIV prevention pill, Reuters Health reports.

    July 3, 2018
    PrEP
    POZ

  • HIV self-testing is greatly preferred to clinic testing by young South African bi/gay men

    A study that gave HIV self-testing kits out to 127 mainly young men who have sex with men (MSM) in two regions in north-east South Africa found that they much preferred using them than going to a clinic for a test.

    July 2, 2018
    General
    aidsmap

  • High cost repels DC college students from HIV drug

    Black college students in DC cite the high cost of PrEP, a drug used to prevent HIV, for why they have spurned the medication…. “I could just continue to use condoms as my protection,” Ajib said. “If insurance were to cover all of it, I would greatly consider using it. HIV or AIDS should not be looked over as a minor thing. It seems like the chances of PrEP helping to prevent it is very useful and should be used if one is able to.”

    July 2, 2018
    PrEP
    Washington Informer

  • Research warns Indonesia gay bashing is fueling HIV epidemic

    The 20-year-old man’s shocking death is a sign of an out-of-control but little acknowledged epidemic of HIV among gay men in Indonesia that researchers say is now being fueled by a gay hate climate whipped up by the country’s conservative political and religious leaders.

    July 2, 2018
    General
    Washington Post

  • Rising cost of PrEP to prevent HIV infection pushes it out of reach for many

    Public health officials are expanding efforts to get the HIV prevention pill into the hands of those at risk, in a nationwide effort to curb infections. But the officials are hitting roadblocks — the drug's price tag, which has surged in recent years, and changes in insurance coverage that put a heftier financial burden on patients.

    June 30, 2018
    PrEP
    NPR

  • Aging HIV population confronts high drug costs, taxes Medicare

    The first generation of AIDS crisis survivors is about to turn 65 and join the Medicare population, putting pressure on federal programs and spotlighting high prescription drug prices.

    June 28, 2018
    General
    BNA

Published Research

Announcements